A combination therapy of ethanol injection and radiofrequency ablation under general anesthesia for the treatment of hepatocellular carcinoma

World J Gastroenterol. 2008 Apr 7;14(13):2037-43. doi: 10.3748/wjg.14.2037.

Abstract

Aim: To summarize the effects of laparoscopic ethanol injection and radiofrequency ablation (L-EI-RFA), thoracoscopic (T-EI-RFA) and open-surgery assisted EI-RFA (O-EI-RFA) under general anesthesia for the treatment of hepatocellular carcinoma (HCC).

Methods: Time-lag performance of RFA after ethanol injection (Time-lag PEI-RFA) was performed in all cases. The volume of coagulated necrosis and the applied energy for total and per unit volume coagulated necrosis were examined in the groups treated under general (group G) or local anesthesia (group L).

Results: The results showed that the total applied energy and the applied energy per unit volume of whole and marginal, coagulated necrosis were significantly larger in group G than those in the group L, resulting in a larger volume of coagulated necrosis in the group G. The rate of local tumor recurrence within one year was extremely low in group G.

Conclusion: These results suggest that EI-RFA, under general anesthesia, may be effective for the treatment of HCC because a larger quantity of ethanol and energy could be applied during treatment under painfree condition for the patients.

Publication types

  • Clinical Trial

MeSH terms

  • Aged
  • Anesthesia, General
  • Carcinoma, Hepatocellular / drug therapy*
  • Carcinoma, Hepatocellular / radiotherapy*
  • Catheter Ablation
  • Combined Modality Therapy / methods
  • Ethanol / pharmacology*
  • Female
  • Humans
  • Laparoscopy / methods
  • Liver Neoplasms / drug therapy*
  • Liver Neoplasms / radiotherapy*
  • Male
  • Middle Aged
  • Necrosis
  • Recurrence
  • Treatment Outcome

Substances

  • Ethanol